• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGubra A/S
    Picture of Gubra A/S logo

    GUBRA — Gubra A/S Share News

    DKK301.600.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapFalling Star
    • Market Cap
      DKK4.95bn
    • Enterprise Value
      DKK4.24bn
    • Revenue
      DKK2.64bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GUBRA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GUBRA Dividends
    • Brief: Gubra Q3 Group Revenue Rises To DKK 53.3 Million

      08/11/2023 06:52
    • Brief: Gubra Enters Into Market Maker Agreement With Sydbank

      26/10/2023 12:20
    • Brief: Gubra Raises Financial Guidance For Full-Year 2023

      26/10/2023 07:23
    • Brief: Gubra Opens Its First US Office In Boston

      24/10/2023 07:17
    • Brief: Gubra Completes Share Buy-Back Programme

      01/09/2023 10:43
    • Brief: Gubra H1 EBIT Loss Widens To DKK 22.8 Mln

      25/08/2023 07:13
    • Brief: Gubra Announces Termination Of Collaboration With Bayer

      23/08/2023 15:47
    • Brief: Gubra Announces Agreement With Hemab

      21/08/2023 14:37
    • Brief: Gubra Raises Financial Guidance For Full-Year 2023

      15/08/2023 12:22
    • Brief: Gubra Acquires Research Service Provider Minigut Aps

      29/06/2023 06:17
    • Brief: Gubra Says Neuropeptide Agonist Shows No Unexpected Safety Concerns

      17/05/2023 06:59
    • Brief: Gubra: Outlook For 2023 Unchanged

      11/05/2023 06:35
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.